A recent study utilizing cryo-EM advances our understanding of how bacterial immune systems function and reveals new aspects ...
Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...
JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing ...
DUBLIN and SAN DIEGO, March 27, 2025 /PRNewswire/ -- ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Jumpcode Genomics ('Jumpcode'), a life science tools company improving and reducing ...
Scientists have worked tirelessly to develop ever more precise and efficient CRISPR-Cas systems to reach the ultimate goal: safe and effective CRISPR-Cas-based medical treatments. Over the years, ...
Grapevine (Vitis vinifera L.) holds significant economic and cultural value, driving the need for rapid genetic improvement to meet climatic and market demands. While traditional breeding is slow and ...
There may be a new entrant soon in the competitive race of gene editing: San Diego’s Isis Pharmaceuticals has teamed up with University of California, San Diego to produce research that demonstrates a ...
The MarketWatch News Department was not involved in the creation of this content. License agreement provides Jumpcode Genomics access to CRISPR gene editing technology to enhance next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results